701 related articles for article (PubMed ID: 30928346)
21. Management of thrombotic thrombocytopenic purpura.
Coppo P;
Transfus Clin Biol; 2017 Sep; 24(3):148-153. PubMed ID: 28645643
[TBL] [Abstract][Full Text] [Related]
22. Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.
Kubo M; Matsumoto M
Int J Hematol; 2023 Mar; 117(3):331-340. PubMed ID: 36757521
[TBL] [Abstract][Full Text] [Related]
23. Emerging roles of adjunct therapies in acquired thrombotic thrombocytopenia purpura.
Racine-Brzostek SE; Shi PA
Transfusion; 2019 Aug; 59(8):2496-2498. PubMed ID: 31283011
[TBL] [Abstract][Full Text] [Related]
24. Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura.
Peyvandi F; Scully M; Kremer Hovinga JA; Knöbl P; Cataland S; De Beuf K; Callewaert F; De Winter H; Zeldin RK
J Thromb Haemost; 2017 Jul; 15(7):1448-1452. PubMed ID: 28445600
[TBL] [Abstract][Full Text] [Related]
25. Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI).
Cid J; Pérez-Valencia AI; Torrente MÁ; Ávarez-Larrán A; Díaz-Ricart M; Esteve J; Lozano M
Transfus Apher Sci; 2021 Feb; 60(1):103011. PubMed ID: 33221124
[TBL] [Abstract][Full Text] [Related]
26. Inherited and acquired thrombotic thrombocytopenic purpura (TTP) in adults.
Knöbl P
Semin Thromb Hemost; 2014 Jun; 40(4):493-502. PubMed ID: 24802084
[TBL] [Abstract][Full Text] [Related]
27. Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura.
Goshua G; Sinha P; Hendrickson JE; Tormey C; Bendapudi PK; Lee AI
Blood; 2021 Feb; 137(7):969-976. PubMed ID: 33280030
[TBL] [Abstract][Full Text] [Related]
28. A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP.
Coppo P; Bubenheim M; Azoulay E; Galicier L; Malot S; Bigé N; Poullin P; Provôt F; Martis N; Presne C; Moranne O; Benainous R; Dossier A; Seguin A; Hié M; Wynckel A; Delmas Y; Augusto JF; Perez P; Rieu V; Barbet C; Lhote F; Ulrich M; Rumpler AC; de Witte S; Krummel T; Veyradier A; Benhamou Y
Blood; 2021 Feb; 137(6):733-742. PubMed ID: 33150928
[TBL] [Abstract][Full Text] [Related]
29. Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura.
George JN
Am J Hematol; 2012 May; 87 Suppl 1():S88-91. PubMed ID: 22407740
[TBL] [Abstract][Full Text] [Related]
30. [Pathogenesis and novel treatment of thrombotic thrombocytopenic purpura].
Matsumoto M
Rinsho Ketsueki; 2021; 62(5):480-485. PubMed ID: 34248125
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023.
Matsumoto M; Miyakawa Y; Kokame K; Ueda Y; Wada H; Higasa S; Yagi H; Ogawa Y; Sakai K; Miyata T; Morishita E; Fujimura Y;
Int J Hematol; 2023 Nov; 118(5):529-546. PubMed ID: 37689812
[TBL] [Abstract][Full Text] [Related]
32. New treatment options for thrombotic thrombocytopenic purpura.
Knöbl P
Hamostaseologie; 2017 Aug; 37(3):211-215. PubMed ID: 28139813
[TBL] [Abstract][Full Text] [Related]
33. An update on the pathogenesis and management of acquired thrombotic thrombocytopenic purpura.
Yarranton H; Machin SJ
Curr Opin Neurol; 2003 Jun; 16(3):367-73. PubMed ID: 12858075
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
Mariotte E; Azoulay E; Galicier L; Rondeau E; Zouiti F; Boisseau P; Poullin P; de Maistre E; Provôt F; Delmas Y; Perez P; Benhamou Y; Stepanian A; Coppo P; Veyradier A;
Lancet Haematol; 2016 May; 3(5):e237-45. PubMed ID: 27132698
[TBL] [Abstract][Full Text] [Related]
36. Recognizing and managing hereditary and acquired thrombotic thrombocytopenic purpura in infants and children.
Siddiqui A; Journeycake JM; Borogovac A; George JN
Pediatr Blood Cancer; 2021 May; 68(5):e28949. PubMed ID: 33660913
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura.
Tsai HM
Kidney Int Suppl; 2009 Feb; (112):S11-4. PubMed ID: 19180123
[TBL] [Abstract][Full Text] [Related]
38. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
Coppo P; Veyradier A
Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and treatment of thrombotic thrombocytopenic purpura].
Kubo M; Matsumoto M
Rinsho Ketsueki; 2020; 61(5):529-535. PubMed ID: 32507820
[TBL] [Abstract][Full Text] [Related]
40. [Thrombotic thrombocytopenic purpura - a rare diagnosis].
Einarsdottir S; Rosander C; Frändberg S; Dezfoolian H; Lisak M
Lakartidningen; 2023 Sep; 120():. PubMed ID: 37712566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
